{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:32:36Z","timestamp":1793158356270,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:00:00Z","timestamp":1793145600000},"content-version":"vor","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jacc.2025.07.037","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:21:51Z","timestamp":1760998911000},"page":"1437-1448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT"],"prefix":"10.1016","volume":"86","author":[{"given":"Catherine G.","family":"Derington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ransmond O.","family":"Berchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9621-9060","authenticated-orcid":false,"given":"Joshua A.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3554-0085","authenticated-orcid":false,"given":"Andrew E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Zheutlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-079X","authenticated-orcid":false,"given":"Jordana B.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Shimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Bress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.07.037_bib1","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.07.037_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jacc.2025.07.037_bib4","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"25_Part_B","key":"10.1016\/j.jacc.2025.07.037_bib5","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.07.037_bib6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib7","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jacc.2025.07.037_bib9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.07.037_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(24)01028-6","article-title":"Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial","volume":"404","author":"Liu","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jacc.2025.07.037_bib12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.jacc.2025.07.037_bib13","doi-asserted-by":"crossref","first-page":"e1162","DOI":"10.1161\/CIR.0000000000000638","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology","volume":"139","author":"Lloyd-Jones","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.07.037_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.23242","article-title":"Performance of the pooled cohort equations to estimate atherosclerotic cardiovascular disease risk by body mass index","volume":"3","author":"Khera","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.07.037_bib15","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2589-7500(21)00236-3","article-title":"Differences in estimates for 10-year risk of cardiovascular disease in Black versus White individuals with identical risk factor profiles using pooled cohort equations: an in silico cohort study","volume":"4","author":"Vasan","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.jacc.2025.07.037_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M17-3011","article-title":"Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk","volume":"169","author":"Yadlowsky","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7326\/M14-1281","article-title":"An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort","volume":"162","author":"DeFilippis","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.07.037_bib19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s11606-019-05361-4","article-title":"The accuracy of cardiovascular pooled cohort risk estimates in U.S. older adults","volume":"35","author":"Nanna","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.07.037_bib21","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.07.037_bib22","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2021.02.058","article-title":"Patient selection for intensive blood pressure treatment based on benefit and adverse events","volume":"77","author":"Bress","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.07.037_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.mayocp.2024.08.024","article-title":"PREVENT and pooled cohort equations in atherosclerotic cardiovascular disease risk prediction: a post hoc analysis of SPRINT","volume":"100","author":"Shetty","year":"2025","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.07.037_bib24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"key":"10.1016\/j.jacc.2025.07.037_bib25","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/HYPERTENSIONAHA.121.17233","article-title":"Blood pressure intervention and control in SPRINT","volume":"79","author":"Cushman","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.07.037_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/hyp.72.suppl_1.069","article-title":"Antihypertensive medication treatment regimens in SPRINT","volume":"72","author":"King","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.07.037_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.117.10479","article-title":"Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial) SPRINT trial","volume":"71","author":"Johnson","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.07.037_bib29","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.07.037_bib31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.07.037_bib32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jacc.2025.07.037_bib33","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/HYPERTENSIONAHA.124.22998","article-title":"Predicted cardiovascular risk by the PREVENT equations in US adults with stage 1 hypertension","volume":"81","author":"Muntner","year":"2024","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.jacc.2025.07.037_bib34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.2024.12537","article-title":"Projected changes in statin and antihypertensive therapy eligibility with the AHA PREVENT cardiovascular risk equations","volume":"332","author":"Diao","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.07.037_bib35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight\u2014reconsidering the use of race correction in clinical algorithms","volume":"383","author":"Vyas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jhm.13294","article-title":"Methodological progress note: how to handle race in research according to the research aim","volume":"19","author":"Sucharew","year":"2024","journal-title":"J Hosp Med"},{"key":"10.1016\/j.jacc.2025.07.037_bib37","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jacc.2019.02.057","article-title":"10-Year risk equations for incident heart failure in the general population","volume":"73","author":"Khan","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725072626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725072626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:43:20Z","timestamp":1793155400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725072626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":36,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0735109725072626"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.07.037","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}